Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 42

1.

Pathways and therapeutic targets in melanoma.

Shtivelman E, Davies MQ, Hwu P, Yang J, Lotem M, Oren M, Flaherty KT, Fisher DE.

Oncotarget. 2014 Apr 15;5(7):1701-52.

PMID:
24743024
[PubMed - in process]
Free PMC Article
2.

Molecular pathways and therapeutic targets in lung cancer.

Shtivelman E, Hensing T, Simon GR, Dennis PA, Otterson GA, Bueno R, Salgia R.

Oncotarget. 2014 Mar 30;5(6):1392-433.

PMID:
24722523
[PubMed - in process]
Free PMC Article
3.

Bezielle selectively targets mitochondria of cancer cells to inhibit glycolysis and OXPHOS.

Chen V, Staub RE, Fong S, Tagliaferri M, Cohen I, Shtivelman E.

PLoS One. 2012;7(2):e30300. doi: 10.1371/journal.pone.0030300. Epub 2012 Feb 3.

PMID:
22319564
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Identification and analysis of the active phytochemicals from the anti-cancer botanical extract Bezielle.

Chen V, Staub RE, Baggett S, Chimmani R, Tagliaferri M, Cohen I, Shtivelman E.

PLoS One. 2012;7(1):e30107. doi: 10.1371/journal.pone.0030107. Epub 2012 Jan 17.

PMID:
22272282
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Bezielle (BZL101)-induced oxidative stress damage followed by redistribution of metabolic fluxes in breast cancer cells: a combined proteomic and metabolomic study.

Klawitter J, Klawitter J, Gurshtein J, Corby K, Fong S, Tagliaferri M, Quattrochi L, Cohen I, Shtivelman E, Christians U.

Int J Cancer. 2011 Dec 15;129(12):2945-57. doi: 10.1002/ijc.25965. Epub 2011 Apr 20.

PMID:
21509784
[PubMed - indexed for MEDLINE]
6.

CC3/TIP30 regulates metabolic adaptation of tumor cells to glucose limitation.

Chen V, Shtivelman E.

Cell Cycle. 2010 Dec 15;9(24):4941-53. Epub 2010 Dec 15.

PMID:
21150275
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Estrogen receptor β causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2.

Paruthiyil S, Cvoro A, Tagliaferri M, Cohen I, Shtivelman E, Leitman DC.

Breast Cancer Res Treat. 2011 Oct;129(3):777-84. doi: 10.1007/s10549-010-1273-5. Epub 2010 Dec 1.

PMID:
21120602
[PubMed - indexed for MEDLINE]
8.

Vascular endothelial platelet endothelial cell adhesion molecule 1 (PECAM-1) regulates advanced metastatic progression.

DeLisser H, Liu Y, Desprez PY, Thor A, Briasouli P, Handumrongkul C, Wilfong J, Yount G, Nosrati M, Fong S, Shtivelman E, Fehrenbach M, Cao G, Moore DH, Nayak S, Liggitt D, Kashani-Sabet M, Debs R.

Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18616-21. doi: 10.1073/pnas.1004654107. Epub 2010 Oct 6. Erratum in: Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3821. Nyack, Shruti [corrected to Nayak, Shruti].

PMID:
20926749
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

CC3/TIP30 affects DNA damage repair.

Fong S, King F, Shtivelman E.

BMC Cell Biol. 2010 Apr 7;11:23. doi: 10.1186/1471-2121-11-23.

PMID:
20374651
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer.

Perez AT, Arun B, Tripathy D, Tagliaferri MA, Shaw HS, Kimmick GG, Cohen I, Shtivelman E, Caygill KA, Grady D, Schactman M, Shapiro CL.

Breast Cancer Res Treat. 2010 Feb;120(1):111-8. doi: 10.1007/s10549-009-0678-5.

PMID:
20054647
[PubMed - indexed for MEDLINE]
11.

Selective concomitant inhibition of mTORC1 and mTORC2 activity in estrogen receptor negative breast cancer cells by BN107 and oleanolic acid.

Chu R, Zhao X, Griffin C, Staub RE, Shoemaker M, Climent J, Leitman D, Cohen I, Shtivelman E, Fong S.

Int J Cancer. 2010 Sep 1;127(5):1209-19. doi: 10.1002/ijc.25116.

PMID:
20027631
[PubMed - indexed for MEDLINE]
12.

Timosaponin AIII is preferentially cytotoxic to tumor cells through inhibition of mTOR and induction of ER stress.

King FW, Fong S, Griffin C, Shoemaker M, Staub R, Zhang YL, Cohen I, Shtivelman E.

PLoS One. 2009 Sep 30;4(9):e7283. doi: 10.1371/journal.pone.0007283.

PMID:
19789631
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Molecular mechanisms underlying selective cytotoxic activity of BZL101, an extract of Scutellaria barbata, towards breast cancer cells.

Fong S, Shoemaker M, Cadaoas J, Lo A, Liao W, Tagliaferri M, Cohen I, Shtivelman E.

Cancer Biol Ther. 2008 Apr;7(4):577-86. Epub 2008 Jan 7.

PMID:
18305410
[PubMed - indexed for MEDLINE]
Free Article
14.

Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer.

Rugo H, Shtivelman E, Perez A, Vogel C, Franco S, Tan Chiu E, Melisko M, Tagliaferri M, Cohen I, Shoemaker M, Tran Z, Tripathy D.

Breast Cancer Res Treat. 2007 Sep;105(1):17-28. Epub 2006 Nov 17.

PMID:
17111207
[PubMed - indexed for MEDLINE]
15.

Inhibition of nuclear import by the proapoptotic protein CC3.

King FW, Shtivelman E.

Mol Cell Biol. 2004 Aug;24(16):7091-101.

PMID:
15282309
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

AHNAK interacts with the DNA ligase IV-XRCC4 complex and stimulates DNA ligase IV-mediated double-stranded ligation.

Stiff T, Shtivelman E, Jeggo P, Kysela B.

DNA Repair (Amst). 2004 Mar 4;3(3):245-56.

PMID:
15177040
[PubMed - indexed for MEDLINE]
17.

Inhibition of Chk1 by activated PKB/Akt.

King FW, Skeen J, Hay N, Shtivelman E.

Cell Cycle. 2004 May;3(5):634-7. Epub 2004 May 31.

PMID:
15107605
[PubMed - indexed for MEDLINE]
Free Article
18.
19.

Multiple developmental roles of Ahnak are suggested by localization to sites of placentation and neural plate fusion in the mouse conceptus.

Downs KM, McHugh J, Copp AJ, Shtivelman E.

Mech Dev. 2002 Dec;119 Suppl 1:S31-8.

PMID:
14516657
[PubMed - in process]
Free Article
20.

Multiple developmental roles of Ahnak are suggested by localization to sites of placentation and neural plate fusion in the mouse conceptus.

Downs KM, McHugh J, Copp AJ, Shtivelman E.

Gene Expr Patterns. 2002 Nov;2(1-2):27-34.

PMID:
12617833
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk